2023 ESMO WCGIC Insights: "Additional Results From the Phase 3 NAPOLI 3 Trial - NALIRIFOX vs. nab-Paclitaxel + Gemcitabine in Treatment-Naïve Patients With mPDAC"

0 views
July 17, 2023
Comments 0
Login to view comments. Click here to Login